According to this perspective, to the best of our knowledge, there is no scientific evidence pointing to the beneficial clinical effects of NRF2 activators in improving cognitive deficits in patients with neurodegenerative diseases. The gene discussed is NFE2L2; the disease is Cognitive impairment.